Not Yet Recruiting OBSERVATIONAL NCT06387407

Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of Dabigatran

Sponsor: The Affiliated Hospital Of Guizhou Medical University

Conditions Combined Analysis of Polymorphisms and Dabigatran Pharmacokinetic Parameters

Interventions Dabigatran Etexilate 150mg

Updated 3 times since 2024 Last updated: Apr 24, 2024 Started: May 1, 2024 Primary completion: Jun 10, 2025 Completion: Nov 25, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06387407, this observational or N/A phase trial focuses on Combined Analysis of Polymorphisms and Dabigatran Pharmacokinetic Parameters and remains actively recruiting participants. Sponsored by The Affiliated Hospital Of Guizhou Medical University, it has been updated 3 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
May 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Affiliated Hospital Of Guizhou Medical University

Data source: The Affiliated Hospital Of Guizhou Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.